M
Marco Volante
Researcher at University of Turin
Publications - 337
Citations - 15058
Marco Volante is an academic researcher from University of Turin. The author has contributed to research in topics: Neuroendocrine tumors & Adrenocortical carcinoma. The author has an hindex of 61, co-authored 305 publications receiving 12987 citations.
Papers
More filters
Journal ArticleDOI
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
Marco Volante,Paola Collini,Yuri E. Nikiforov,Atsuhiko Sakamoto,Kennichi Kakudo,Ryohei Katoh,Ricardo V. Lloyd,Virginia A. LiVolsi,Mauro Papotti,Manuel Sobrinho-Simões,Gianni Bussolati,Juan Rosai +11 more
TL;DR: To compare lesions occurring in different geographic areas and the diagnostic criteria applied in those countries, a study with a panel of internationally recognized thyroid pathologists to develop consensus diagnostic criteria for PD carcinomas was designed.
Journal ArticleDOI
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
Paolo Ceppi,Marco Volante,Silvia Saviozzi,Ida Rapa,Silvia Novello,A. Cambieri,Marco Lo Iacono,Susanna Cappia,Mauro Papotti,Giorgio V. Scagliotti +9 more
TL;DR: In patients with cancer, one of the main mechanism of resistance to antimetabolite drugs is related to higher levels of thymidylate synthase (TS) activity.
Journal ArticleDOI
Expression of Ghrelin and of the GH Secretagogue Receptor by Pancreatic Islet Cells and Related Endocrine Tumors
Marco Volante,Elena Allia,Patrizia Gugliotta,Ada Funaro,Fabio Broglio,Romano Deghenghi,Giampiero Muccioli,Ezio Ghigo,Mauro Papotti +8 more
TL;DR: Findings demonstrate that ghrelin production is not restricted to the stomach but is also present in pancreatic beta-cells and endocrine tumors (regardless of the type of pancreatic hormone produced, if any).
Journal ArticleDOI
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.
Mauro Papotti,Massimo Bongiovanni,Marco Volante,Elena Allia,Landolfi S,L. Helboe,Marcus Schindler,Cole Sl,Giovanni Bussolati +8 more
TL;DR: It is concluded that SSTRs 1–5 are heterogeneously expressed in GEP endocrine tumors and that IHC is a reliable tool to detect SSTR types 2, 3 and 5 in surgical and biopsy specimens.
Journal ArticleDOI
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
Paolo Ceppi,Marco Volante,Silvia Novello,Ida Rapa,K. Danenberg,Peter V. Danenberg,A. Cambieri,Giovanni Selvaggi,Silvia Saviozzi,Raffaele A. Calogero,Mauro Papotti,Giorgio V. Scagliotti +11 more
TL;DR: This retrospective study further validates ER CC1 and RRM1 genes as reliable candidates for customized chemotherapy and shows a higher impact on the survival of NSCLC patients treated with cisplatin/gemcitabine for ERCC1.